When Labeling Goes Bad: The Case of the Opposite Hands

Everything was running smoothly in the run-up to launching the new drug formulation.  Development of the drug finished ahead of schedule; regulatory requirements had been met; and intellectual property rights secured. Next up were the all-important clinical trials to demonstrate the efficacy of the drug.